Semaglutide – 5 mg / 10 mg
Price range: $149.99 through $999.98
Semaglutide is a long-acting GLP-1 receptor agonist widely recognized for appetite, glucose-control and weight-management support. This lyophilized vial is offered with a stated strength of 5 mg; 10 mg.
Potential Benefits and Product Highlights
- Helps promote satiety and reduced appetite.
- Supports glucose-dependent insulin signaling and post-meal metabolic control.
- Strong human evidence for weight-management and glycemic outcomes in approved formulations.
- Long-acting molecular design supports sustained GLP-1 receptor activity.
- Independent third-party testing with lot-specific quality documentation.
Product Details
| Product name | Semaglutide – 5 mg / 10 mg |
|---|---|
| Main category | Peptides |
| Subcategory | Weight Management Peptides |
| Product format | Lyophilized vial |
| Declared strength | 5 mg; 10 mg |
| Active identity / composition | Semaglutide |
| Quality documentation | Independent third-party testing and lot-specific Certificate of Analysis |
Chemical Information
| Compound | Amount | Molecular formula | Molecular weight | Sequence / structure |
|---|---|---|---|---|
| Semaglutide | 5 mg / 10 mg | C₁₈₇H₂₉₁N₄₅O₅₉ | 4113.58 g/mol | H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys[γ-Glu-2×OEG-C18 diacid]-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
How It Works
Semaglutide mimics GLP-1, a gut-derived incretin hormone. GLP-1 receptor activation slows gastric emptying, increases glucose-dependent insulin secretion and sends satiety signals to the brain.
Retatrutide – 10 mg / 30 mg extends beyond GLP-1 by adding GIP and glucagon receptor activity to its metabolic profile.
Evidence note: Benefits and risks are well studied in approved prescription formulations. Product identity, strength and professional supervision remain important.
Sources: FDA. Ozempic prescribing information, 2025; FDA. Wegovy prescribing information, 2025; PubChem. Semaglutide compound record.
Product Strength and Usage Information
This lyophilized vial is offered with a stated strength of 5 mg; 10 mg. Check the current label, serving or unit information and lot-specific documentation before use.
No single dosage suits every compound, goal or customer. Use should follow the product label and appropriate professional guidance, especially for potent hormones, prescription-class ingredients and investigational compounds.
Quality and Testing
Identity, purity and finished-product content are reviewed as separate quality attributes. The lot-specific Certificate of Analysis should identify the methods, results, batch number, testing provider and test date.
- Chromatographic testing evaluates purity and related substances.
- Mass spectrometry supports molecular identity and expected mass.
- Finished-product testing evaluates the supplied concentration, unit content, fill, count, uniformity or physical presentation as applicable.
- Lot-specific documentation supports confident purchasing and product traceability.
Storage and Handling
- Keep the sealed vial under the temperature conditions printed on the product label.
- Protect from light, moisture and repeated temperature changes.
- After reconstitution, follow the stated refrigeration and use-period instructions.
- Avoid repeated freeze-thaw cycles and inspect the vial before use.
Frequently Asked Questions
What is included in this product?
Semaglutide – 5 mg / 10 mg supplied in a lyophilized vial with the declared composition and strength shown in the specifications.
What is Semaglutide – 5 mg / 10 mg?
Semaglutide is a long-acting GLP-1 receptor agonist widely recognized for appetite, glucose-control and weight-management support.
What potential benefits are associated with it?
Potential areas of interest include helps promote satiety and reduced appetite, supports glucose-dependent insulin signaling and post-meal metabolic control, strong human evidence for weight-management and glycemic outcomes in approved formulations.
How does it work?
Semaglutide mimics GLP-1, a gut-derived incretin hormone. GLP-1 receptor activation slows gastric emptying, increases glucose-dependent insulin secretion and sends satiety signals to the brain.
How strong is the evidence?
Benefits and risks are well studied in approved prescription formulations. Product identity, strength and professional supervision remain important.
How is product quality documented?
Independent third-party testing and a lot-specific Certificate of Analysis provide identity, purity and finished-product information.
How should the product be stored?
Keep the product in its original container and follow the temperature, light and handling conditions shown on the label.
What should be checked when the product arrives?
Review the product name, format, strength, lot number, container integrity and matching Certificate of Analysis.
Related products
BPC-157 (5mg, 10mg)
Selank (5mg)
TB-500 (High Dose Oral)
GHRP-2 (5mg)
CJC 1295 With DAC
